Results 171 to 180 of about 346,283 (289)
Inhalation of Formalin in Catarrh and Other Diseases of the Respiratory Tract [PDF]
, 1897 J. L. Green
openalex +1 more source
International Forum of Allergy &Rhinology, EarlyView.ABSTRACT Background Type 2 inflammation dominates eosinophilic chronic rhinosinusitis (eCRS) and adult onset asthma. IL‐4, ‐5, and ‐13 are prominent disease mediators. Disease control can be achieved with biologic therapies. However, despite some patients entering remission, others experience poor control. Aim We aimed to describe eCRS patients treated
Peta‐Lee Sacks +8 more
wiley +1 more source
COVID‐19 and myasthenia gravis: A review of neurological implications of the SARS‐COV‐2
Brain and Behavior, Volume 12, Issue 12, December 2022., 2022 Abstract Introduction This review highlights the potential mechanisms of neuromuscular manifestation of COVID‐19, especially myasthenia gravis (MG). Methods An extensive literature search was conducted by two independent investigators using PubMed/MEDLINE and Google Scholar from its inception to December 2020. Results Exacerbations of clinical symptoms
Syed Muhammad Ismail Shah +10 more
wiley +1 more source
Pseudothrombocytopenia due to Phagocytosis of Platelets by Polymorphonuclear Leukocytes
American Journal of Hematology, EarlyView.
Iliana Stamatiou +4 more
wiley +1 more source
Cancer Communications, Volume 42, Issue 12, Page 1314-1330, December 2022., 2022 Abstract Background Treatment options for Chinese patients with locally advanced or metastatic squamous‐cell non‐small‐cell lung cancer (sqNSCLC) after failure of first‐line chemotherapy are limited. This study (ORIENT‐3) aimed to evaluate the efficacy and safety of sintilimab versus docetaxel as second‐line treatment in patients with locally advanced ...
Yuankai Shi +45 more
wiley +1 more source
Noisy upper respiratory tract secretions: pharmacological management [PDF]
, 2019 Boland, Elaine G, Boland, Jason W.
core +1 more source
General considerations of the mucous membrances of the upper respiratory tract [PDF]
, 1899 openalex +1 more source
Elexacaftor–Tezacaftor–Ivacaftor Improves Sinonasal Outcomes in Young Children With Cystic Fibrosis
International Forum of Allergy &Rhinology, EarlyView.ABSTRACT Background Severe chronic rhinosinusitis (CRS) is a near universal manifestation of cystic fibrosis. Elexacaftor/tezacaftor/ivacaftor (ETI) is an oral, small molecule, highly effective Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) corrector–potentiator drug.
Amanda L. Stapleton +10 more
wiley +1 more source
The climatic influence of our southwestern states on diseases of the respiratory tract [PDF]
, 1898 openalex +1 more source